当前位置:首页 - 行情中心 - 翔宇医疗(688626) - 财务分析 - 现金流量表

翔宇医疗

(688626)

  

流通市值:84.50亿  总市值:84.50亿
流通股本:1.60亿   总股本:1.60亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金645,583,603.09437,110,263.39217,513,974.91867,521,952.22
  收到的税费返还12,966,123.457,897,672.486,298,746.5115,760,854.41
  收到其他与经营活动有关的现金34,831,988.8924,952,835.3714,911,313.0542,207,463.61
  经营活动现金流入小计693,381,715.43469,960,771.24238,724,034.47925,490,270.24
  购买商品、接受劳务支付的现金213,499,494.6142,961,167.1887,281,076.14244,882,106.53
  支付给职工以及为职工支付的现金241,620,921.61161,584,128.377,478,682267,520,661.1
  支付的各项税费51,986,550.7131,695,124.5517,272,543.2359,971,458.63
  支付其他与经营活动有关的现金115,077,243.9380,524,005.7135,847,516.83174,521,604.82
  经营活动现金流出小计622,184,210.85416,764,425.74217,879,818.2746,895,831.08
  经营活动产生的现金流量净额71,197,504.5853,196,345.520,844,216.27178,594,439.16
二、投资活动产生的现金流量:
  收回投资收到的现金5,150,7125,150,712--
  取得投资收益收到的现金984,195.39931,405.6422,125.611,255,114.34
  处置固定资产、无形资产和其他长期资产收回的现金净额26,252.9321,374.06137.9880,500
  收到的其他与投资活动有关的现金100,000,000--332,000,000
  投资活动现金流入小计106,161,160.326,103,491.66422,263.59333,335,614.34
  购建固定资产、无形资产和其他长期资产支付的现金251,271,437.94192,917,997.2485,263,693.95438,890,635.9
  投资支付的现金---200,000
  支付其他与投资活动有关的现金150,000,000100,000,000100,000,000170,000,000
  投资活动现金流出小计401,271,437.94292,917,997.24185,263,693.95609,090,635.9
  投资活动产生的现金流量净额-295,110,277.62-286,814,505.58-184,841,430.36-275,755,021.56
三、筹资活动产生的现金流量:
  吸收投资收到的现金66,807,16017,849,160--
  取得借款收到的现金263,693,438.9233,090,000181,090,000338,000,000
  收到其他与筹资活动有关的现金488,000,000411,000,000327,849,160178,000,000
  筹资活动现金流入小计818,500,598.9661,939,160508,939,160516,000,000
  偿还债务支付的现金298,990,000203,990,000106,990,000189,010,000
  分配股利、利润或偿付利息支付的现金42,475,118.7240,915,441.237,284,247.4785,865,792.27
  其中:子公司支付给少数股东的股利、利润---275,000
  支付其他与筹资活动有关的现金221,896,833.49181,003,394.59201,896,833.4992,746,208.54
  筹资活动现金流出小计563,361,952.21425,908,835.82316,171,080.96367,622,000.81
  筹资活动产生的现金流量净额255,138,646.69236,030,324.18192,768,079.04148,377,999.19
四、汇率变动对现金及现金等价物的影响-6,128.23-84,566.119,167.12-72,176.93
五、现金及现金等价物净增加额31,219,745.422,327,59828,790,032.0751,145,239.86
  加:期初现金及现金等价物余额702,912,552.43702,912,552.43702,912,552.43651,767,312.57
  期末现金及现金等价物余额734,132,297.85705,240,150.43731,702,584.5702,912,552.43
补充资料:
  净利润-33,482,193.16-102,853,096.06
  资产减值准备-2,353,330.71-9,188,838.54
  固定资产和投资性房地产折旧-21,285,691.33-30,565,107.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-21,285,691.33-30,565,107.15
  无形资产摊销-3,961,444.95-7,255,483.58
  长期待摊费用摊销-2,029,115.05-2,248,199.31
  处置固定资产、无形资产和其他长期资产的损失-21,374.06--66,478.93
  固定资产报废损失---49,296.68
  财务费用-3,846,168.64-3,555,583.6
  投资损失--6,082,117.6--1,400,899.49
  递延所得税-2,048,179.59-1,665,336.41
  其中:递延所得税资产减少-2,048,179.59-1,665,336.41
  存货的减少--26,806,380.69--6,004,621.48
  经营性应收项目的减少--8,894,867.75--20,713,241.22
  经营性应付项目的增加-24,122,208.94-38,226,045.67
  其他---5,101,686.26
  现金的期末余额-705,240,150.43-702,912,552.43
  减:现金的期初余额-702,912,552.43-651,767,312.57
  现金及现金等价物的净增加额-2,327,598-51,145,239.86
公告日期2025-10-312025-08-292025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑